Award
Delivery Order #SPE2DP26F6482
Delivery Order for MOXIFLOXACIN HYDROC Under Existing Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$862.50
Ceiling
$862.50
Awarded
June 10, 2026
Period of Performance
Jun 10, 2026 – Jun 10, 2026
Identifier
SPE2DP26F6482
NAICS
424210
This award is a delivery order placed under an existing definitive indefinite delivery vehicle (IDV) pharmaceutical supply contract held by DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceutical products. The order specifically procures MOXIFLOXACIN HYDROC, an essential pharmaceutical, contributing to the federal health agencies' critical medication supplies. The contract supports ongoing public health efforts by ensuring timely availability and delivery of this vital drug consistent with healthcare needs. This delivery order falls within a broader long-term multi-year definitive contract aimed at maintaining a reliable inventory of diverse pharmaceuticals for various medical treatments. Awarded through a competitive procurement process, the order reflects prompt fulfillment with a single-day performance timeline. It strengthens the sustained collaboration established by the parent contract, which covers a wide portfolio including injectable solutions, topical creams, and oral tablets, underscoring its importance to federal health provisioning.
Description
8512173480!MOXIFLOXACIN HYDROC